Henry Schein income statement

In fiscal 2025, Henry Schein reported revenue of $13.18bn, up 4.0% on the year before, operating income of $653m (a 5.0% margin) and net income of $398m, or $3.27 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Henry Schein: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	6.5	7.5	8.5	8.9	9.6	10.4	10.6	11.6	12.5	13.2	10.0	10.1	12.4	12.6	12.3	12.7	13.2	13.7
Cost of revenue	—	—	6.1	6.4	6.9	7.5	7.6	8.3	6.1	6.5	6.9	7.3	8.7	8.8	8.5	8.7	9.1	9.4
Gross profit	1.9	2.2	2.4	2.5	2.7	2.9	3.0	3.2	2.7	2.9	3.1	2.8	3.7	3.8	3.9	4.0	4.1	4.3
Selling, general and administrative	1.4	1.6	1.8	1.9	2.0	2.2	2.2	2.4	2.1	2.2	2.4	2.1	2.6	2.8	3.0	3.0	3.1	3.3
Operating income	0.5	0.5	0.6	0.6	0.7	0.7	0.7	0.8	0.7	0.6	0.7	0.5	0.9	0.7	0.6	0.6	0.7	0.7
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2
Income before tax	0.5	0.5	0.6	0.6	0.7	0.7	0.7	0.8	0.6	0.5	0.7	0.5	0.8	0.7	0.5	0.5	0.5	0.6
Income tax	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1
Net income	0.3	0.3	0.4	0.4	0.4	0.5	0.5	0.5	0.4	0.5	0.7	0.4	0.6	0.5	0.4	0.4	0.4	0.4
Diluted EPS	$1.72	$1.75	$1.99	$2.16	$2.46	$2.72	$2.85	$3.10	$2.57	$3.49	$4.65	$2.82	$4.45	$3.91	$3.16	$3.05	$3.27	$3.65
Diluted shares (average)	181m	187m	185m	180m	175m	171m	168m	164m	158m	154m	149m	143m	142m	138m	132m	128m	122m	115m
EBITDA	0.5	0.6	0.7	0.7	0.8	0.9	0.9	0.9	0.8	0.7	0.9	0.7	1.1	1.0	0.9	0.9	1.0	1.0

US$ millions unless shown otherwise. Fiscal quarters.

Henry Schein: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	3,191	3,168	3,240	3,339	3,437	3,368	3,458	3,471
Cost of revenue	2,198	2,168	2,224	2,313	2,374	2,298	2,357	2,366
Gross profit	993	1,000	1,016	1,026	1,063	1,070	1,101	1,105
Selling, general and administrative	738	738	778	760	808	809	831	819
Operating income	155	175	151	164	163	182	171	193
Interest expense	35	35	38	38	39	39	43	42
Income before tax	126	145	121	134	133	150	137	160
Income tax	31	35	31	28	32	38	34	37
Net income	94	110	86	101	101	107	94	119
Diluted EPS	$0.75	$0.88	$0.70	$0.84	$0.85	$0.92	$0.82	$1.06
EBITDA	231	248	227	244	245	263	255	279

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HSIC vs YI COR vs HSIC HSIC vs MCK COSM vs HSIC

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Henry Schein's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Henry Schein.